Group 1 - The company held its 23rd meeting of the second board of directors on August 26, 2025, with all 9 directors present, and the meeting was chaired by Chairman Zhen Lixin [1][2] - The board approved the draft of the 2025 Restricted Stock Incentive Plan, which aligns with relevant laws and regulations, and is expected to benefit the company's sustainable development [2][5] - The board also approved the management measures for the implementation of the 2025 Restricted Stock Incentive Plan, ensuring its smooth execution and alignment with the company's governance structure [2][3] Group 2 - The board proposed to authorize the board to handle matters related to the 2025 Restricted Stock Incentive Plan, including determining eligibility, adjusting stock quantities, and managing the vesting process [5][6] - The board agreed to convene the second extraordinary general meeting of shareholders on September 17, 2025, to discuss the approved proposals [6][7]

Core Viewpoint - The legal opinion letter from Fangda Partners addresses the adjustments to the stock incentive plan of Shanghai Aopumai Biotechnology Co., Ltd., including the adjustment of grant prices, the cancellation of unvested shares, and the confirmation of vesting conditions for certain stock grants [1][6][19]. Summary by Sections Legal Framework - The legal opinion is based on various Chinese laws and regulations, including the Company Law, Securities Law, and specific guidelines from the China Securities Regulatory Commission and the Shanghai Stock Exchange [2][3]. Price Adjustment - The stock grant price for the incentive plan was adjusted from 25.00 CNY per share to 24.14 CNY per share, following the calculation of dividends distributed to shareholders [10][11][19]. Cancellation of Shares - A total of 35,000 shares were confirmed to be canceled due to the departure of two incentive recipients who no longer qualified for the incentive program [12][13][19]. Vesting Conditions - The vesting conditions for the first grant's second vesting period and the reserved grant's first vesting period have been met, confirming a total of 297,800 shares eligible for vesting, with 264,000 shares from the first grant and 33,800 shares from the reserved grant [18][19].

证券代码：688293 证券简称：奥浦迈 公告编号：2025-074 通过了《关于确认作废 <公司 ensp="ensp" 年限制性股票激励计划="年限制性股票激励计划"> 部分已授 予尚未归属 上海奥浦迈生物科技股份有限公司 关于确认作废公司 2023 年限制性股票激励计划部分 已授予尚未归属的限制性股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 上海奥浦迈生物科技股份有限公司（以下简称"公司"或"奥浦迈"）于 2025 年 9 月 1 日召开第二届董事会第十二次会议、第二届监事会第十一次会议，审议 的限制性股票的议案》，现将相关事项公告如下： 一、本次限制性股票授予已履行的决策程序和信息披露情况 《关于 <公司 ensp="ensp" 年限制性股票激励计划="年限制性股票激励计划" 草案="草案"> 及其摘要的 议案》 《关于 <公> 司 2023 年限制性股票激励计划实施考核管理办法>的议案》《关于提请股东大会 授权董事会办理公司股权激励计划相关事宜的议案》等议案，公司独立董事就本 激励计划相关议案发表了 ...

Core Viewpoint - The company has approved the reserve grant list for the 2024 restricted stock incentive plan, ensuring compliance with relevant regulations and internal procedures [1][2]. Group 1: Public Disclosure and Verification - The public disclosure included the names and positions of the reserve grant incentive objects [2]. - The public disclosure period was from August 22, 2025, to August 31, 2025, lasting a total of 10 days [2]. - The disclosure was conducted internally, and feedback was collected through designated phone lines, email, or in-person communication, with no objections received during the public disclosure period [2][3]. Group 2: Review and Compliance - The Compensation and Assessment Committee of the Board verified the eligibility of the reserve grant incentive objects against the criteria set forth in the management regulations and the draft incentive plan [2][3]. - The committee confirmed that all individuals listed in the reserve grant incentive objects met the necessary qualifications and conditions as per the relevant laws and regulations [3].

Core Viewpoint - The announcement details the public disclosure and verification opinions regarding the list of incentive objects for the 2025 restricted stock incentive plan of Tonghua Grape Wine Co., Ltd. [1][2][3] Disclosure and Verification - The company publicly disclosed the list of incentive objects on the Shanghai Stock Exchange website and through internal postings [1] - The Board's Compensation and Assessment Committee verified the list of incentive objects, including their identification documents and employment contracts [2] Verification Opinions - All individuals included in the incentive object list are current employees of the company or its subsidiaries, meeting the qualifications set forth in relevant laws and regulations [2] - The basic information of the incentive objects is accurate, with no falsehoods or significant omissions [2] - None of the incentive objects fall under the disqualifications outlined in the regulations, such as being subject to market entry bans [2] - The list does not include independent directors or shareholders holding more than 5% of the company's shares [2][3]

Core Points - The company held its 28th meeting of the 6th Board of Directors on September 1, 2025, where it approved adjustments to the 2023 Restricted Stock Incentive Plan [1][2] - A total of 467,500 shares of the second category of restricted stock that had been granted but not yet vested will be canceled due to the departure of 12 incentive targets and performance failures [1][2] - After the adjustments, the number of incentive targets eligible for the second category of restricted stock will be reduced to 231, with 15,380,000 shares being granted to those meeting the vesting conditions [2][3] Summary by Sections Meeting Details - The meeting was convened via electronic means with all 7 directors present, complying with relevant laws and regulations [1] - The meeting was chaired by Chairman Li Boyang [1] Adjustments to Incentive Plan - The board approved the cancellation of 380,000 shares for 12 departed incentive targets and 87,500 shares for one target who did not meet performance criteria [1][2] - The total number of shares canceled amounts to 467,500 [2] Approval of Vesting Conditions - The board confirmed that the vesting conditions for the second vesting period have been met for 231 eligible incentive targets [2][3] - The decision was supported by a vote of 5 in favor, with no opposition or abstentions from non-related directors [2][3]

Core Points - The supervisory board of Beijing Hekang New Energy Technology Co., Ltd. has reviewed the list of eligible participants for the first vesting period of the 2023 restricted stock incentive plan [1] - Out of 53 reserved grant incentive objects, 36 individuals meet the qualifications for the incentive plan, while 16 lost eligibility due to resignation and 1 failed to meet performance evaluation criteria [1] - The total number of shares corresponding to the eligible 36 participants is 2.075 million shares, and the actions taken comply with relevant laws and regulations [2]

Group 1 - The sixth session of the Supervisory Board of Beijing Hekang New Energy Technology Co., Ltd. was held on September 1, 2025, with all three supervisors present, either in person or via communication [1] - The Supervisory Board unanimously agreed to cancel a total of 1.725 million unvested restricted stocks, which complies with the company's 2023 Restricted Stock Incentive Plan and does not harm shareholder interests [1][2] - The Supervisory Board confirmed that the conditions for the first vesting period of the reserved grant portion of the incentive plan have been met, allowing for the vesting of stocks for 36 eligible incentive objects [2] Group 2 - The company plans to increase the quota for foreign exchange hedging business to mitigate risks associated with currency fluctuations and interest rate changes, reflecting the growth of its overseas business [3]

Group 1 - The company held its 23rd meeting of the 6th Board of Directors on September 1, 2025, with both in-person and remote participation [1] - The Board decided to cancel 1.725 million shares of unvested restricted stock due to 16 incentive targets leaving the company and one target failing to meet the first vesting period assessment [1][2] - The Board approved the vesting of 2.075 million shares of restricted stock for 36 incentive targets who met the vesting conditions [2] Group 2 - The company plans to increase its foreign exchange hedging business limit to mitigate risks associated with currency fluctuations, with a maximum limit of RMB 500 million or equivalent foreign currency [3] - The peak margin for the foreign exchange hedging business will not exceed RMB 100 million or equivalent foreign currency [3] - The proposal for increasing the foreign exchange hedging limit was approved by the Board and will be submitted for shareholder meeting approval [3][4]

Group 1 - The company held the 26th meeting of the sixth Supervisory Board on September 1, 2025, with all three supervisors present, complying with relevant laws and regulations [1] - The Supervisory Board approved the adjustment of the number of incentive targets for the 2023 Restricted Stock Incentive Plan and the cancellation of certain granted but unvested second-class restricted stocks, ensuring compliance with the relevant regulations [1][2] - The adjustment was deemed to not harm the interests of the company and its shareholders, confirming the legality and validity of the incentive targets [1] Group 2 - The Supervisory Board also approved the achievement of the vesting conditions for the second vesting period of the 2023 Restricted Stock Incentive Plan, validating the vesting qualifications of 231 incentive targets [2] - A total of 15,380,000 shares of restricted stock are eligible for vesting for the approved incentive targets [2]